---
layout: entry
title: "Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic"
link: "https://doi.org/10.1111/bjd.19161"
author:
- Mahil, S. K.; Yiu, Z. Z. N.; Mason, K. J.; Dand, N.; Coker, B.; Wall, D.; Fletcher, G.; Bosma, A.; Capon, F.; Iversen, L.; Langan, S. M.; Di Meglio, P.; Musters, A.; Prieto-Merino, D.; Tsakok, T.; Warren, R. B.; Flohr, C.; Spuls, P.; Griffiths, C. E. M.; Barker, J.; Irvine, A. D.; Smith, C. H.; The Secure-Ad, PsoPROTECT study groups

summary:
- "PsoPROTECT and SECURE-AD registries address unmet need for delineating COVID-19 outcomes. Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion and atopic dermatitis. We want to bring your attention to the PssoProtECT and the Registries. They address the urgent global initiatives that address the need for determinants."

original:
- "We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis."
---

